BIOMAT Database Logo BIOMAT Database Logo

Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. 1994

R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

OBJECTIVE The evaluation of the role of polymorphism within the class II encoded antigen processing genes, LMP2 and TAP, in susceptibility to ankylosing spondylitis (AS). METHODS Eighty five patients with ankylosing spondylitis, 35 B27 positive healthy controls, and 55 unrelated healthy controls were studied. TAP1 and TAP2 alleles were assigned by ARMS PCR, and LMP2 alleles were assigned by restriction enzyme digestion of a PCR product. RESULTS The TAP1C allele was increased in the AS group (6%) compared with random controls (1%), p = 0.03 and TAP2E was increased in AS (3.5%) compared with random controls (0%), p = 0.05. However, the frequencies of these alleles were also increased in B27 matched controls. There were no differences in LMP2 allele or genotype frequencies between AS and either of the control groups. Partitioning of patients according to presence or absence of uveitis did not reveal any significant associations. CONCLUSIONS Increases of the minor TAP alleles, 1C and 2E, in AS reflect linkage disequilibrium between these alleles and HLA-B27. Polymorphism of the class I antigen processing pathway does not contribute significantly to AS susceptibility nor to the development of anterior uveitis associated with AS.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
HLA class I and II alleles in susceptibility to ankylosing spondylitis.
January 2019, Annals of the rheumatic diseases,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
HLA-DM and the MHC class II antigen presentation pathway.
January 1999, Immunologic research,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.
January 2004, Cancer research,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
Protein sorting within the MHC class II antigen-processing pathway.
January 1998, Immunologic research,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
Measurement of HLA class I expression in ankylosing spondylitis.
October 1992, Annals of the rheumatic diseases,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
Virtual models of the HLA class I antigen processing pathway.
December 2004, Methods (San Diego, Calif.),
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
Proteome sampling by the HLA class I antigen processing pathway.
January 2012, PLoS computational biology,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
Different regulation of MHC class I antigen processing components in human tumors.
October 2008, Journal of immunotoxicology,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
HLA class I and class II association with ankylosing spondylitis in a southern Indian population.
April 2002, Annals of the New York Academy of Sciences,
R O Burney, and K D Pile, and K Gibson, and A Calin, and L G Kennedy, and P J Sinnott, and S H Powis, and B P Wordsworth
MHC class I antigen processing pathways.
May 1997, Human immunology,
Copied contents to your clipboard!